Krishna Murthy Thopudurthi

Title: Innovations of Krishna Murthy Thopudurthi

Introduction

Krishna Murthy Thopudurthi is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for the preparation of dapagliflozin, a medication used to treat diabetes. With a total of 2 patents to his name, his work has had a meaningful impact on medical science.

Latest Patents

His latest patents focus on improved processes for the preparation of dapagliflozin or its solvates or co-crystals. The first patent describes an enhanced method for synthesizing dapagliflozin, which is an inhibitor of sodium-dependent glucose transporters. This invention not only details the process but also introduces novel intermediates that can be utilized in the preparation of dapagliflozin. The second patent reiterates these improved processes and emphasizes the significance of the intermediates in the synthesis of dapagliflozin.

Career Highlights

Krishna Murthy Thopudurthi is currently associated with Laurus Labs Private Limited, a prominent player in the pharmaceutical industry. His role at Laurus Labs has allowed him to focus on innovative drug development, contributing to the company's reputation for excellence in research and development.

Collaborations

He has collaborated with several talented individuals in his field, including Uma Maheswar Rao Vasireddi and Sanjay Kumar Dehury. These collaborations have fostered a productive environment for innovation and have led to advancements in pharmaceutical processes.

Conclusion

In summary, Krishna Murthy Thopudurthi is a distinguished inventor whose work in the preparation of dapagliflozin has made a significant impact in the pharmaceutical industry. His contributions continue to advance medical science and improve treatment options for diabetes.